S. Kwa

发表

Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates

B. Korber, D. Montefiori, O. Yang, 2015, Journal of Virology.

Viral Control with Diminished Antiviral T Cell Response CorrelatesImmunodeficiency Virus Infection Following a Pathogenic Simian Suppressive Potential in Colorectal Mucosa CD 8 T Cells with + Expansion of FOXP 3

P. Nigam, M. Siddiqui, R. Amara, 2010 .

CD 40 L-Adjuvanted DNA / Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV 239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE 660 Mucosal Challenge

B. Moss, D. Montefiori, Tianwei Yu, 2022 .

Peyer’s Patches Are Required for the Induction of Rapid Th1 Responses in the Gut and Mesenteric Lymph Nodes during an Enteric Infection1

P. Beverley, Adrian L. Smith, S. Kwa, 2006, The Journal of Immunology.

Expansion of FOXP3+ CD8 T Cells with Suppressive Potential in Colorectal Mucosa Following a Pathogenic Simian Immunodeficiency Virus Infection Correlates with Diminished Antiviral T Cell Response and Viral Control

P. Nigam, M. Siddiqui, R. Amara, 2010, The Journal of Immunology.

Plasmacytoid dendritic cells are recruited to the colorectum and contribute to immune activation during pathogenic SIV infection in rhesus macaques.

G. Silvestri, P. Nigam, S. Bosinger, 2011, Blood.

CD40L-Adjuvanted DNA/Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE660 Mucosal Challenge

B. Moss, D. Montefiori, Tianwei Yu, 2014, Journal of Virology.

Loss of IL-17–Producing CD8 T Cells during Late Chronic Stage of Pathogenic Simian Immunodeficiency Virus Infection

P. Nigam, R. Amara, V. Velu, 2011, The Journal of Immunology.

InfectionLate Chronic Stage of Pathogenic SIV Producing CD8 T Cells during - Loss of IL-17

V. Velu, S. Kwa, 2010 .

Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine.

P. Earl, B. Moss, D. Montefiori, 2011, The Journal of infectious diseases.

DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus

B. Palmer, B. Keele, N. Chomont, 2016, PloS one.

Diminished Viral Control during Simian Immunodeficiency Virus Infection Is Associated with Aberrant PD-1hi CD4 T Cell Enrichment in the Lymphoid Follicles of the Rectal Mucosa

J. Hong, R. Amara, B. Lawson, 2014, The Journal of Immunology.

Rectal Mucosa Enrichment in the Lymphoid Follicles of the CD 4 T CellhiAssociated with Aberrant PD-1 Immunodeficiency Virus Infection Is Diminished Viral Control during Simian

J. Hong, R. Amara, B. Lawson, 2014 .

SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses.

M. Hudgens, P. Earl, B. Moss, 2012, Vaccine.

CD40L-Adjuvanted DNA/Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus (SIV) Vaccine Enhances Protection against Neutralization-Resistant Mucosal SIV Infection

B. Moss, D. Montefiori, C. Labranche, 2015, Journal of Virology.

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine

B. Haynes, B. Moss, D. Montefiori, 2017, Journal of Virology.